Although no threshold has been established for protective immunity, antibody levels in vaccinated solid organ transplant recipients were well below that which has been observed in immunocompetent patients.
Investigators recommended close surveillance after COVID-19 vaccination of kidney transplant recipients and suggested the possibility that a third dose may be required in less responsive patients.
In adjusted analyses, related donor-recipient pairs had a significant 5% increased risk for allograft failure compared with unrelated donor-recipient pairs.
Interventions may be needed to achieve gender and racial equity in access to kidney transplantation across end-stage renal disease networks in the United States.
Investigators report encouraging results from a small observational study testing the effect of preemptive therapeutic plasma exchange and rituximab in kidney transplant recipients whose primary cause of kidney failure was focal segmental glomerulosclerosis.
Kidney transplant candidates aged 65 years or older significantly improved their survival by receiving a standard rather than an expanded criteria donor kidney or continuing on dialysis, a Belgian study showed.
